Alison C. Macleod

Combination Therapy for KIT-Mutant Mast Cells: Targeting Constitutive NFAT and KIT Activity

Janice Patterson, M. Heinrich, D. Griffith, 2014, Molecular Cancer Therapeutics.

Combination Treatment to Target KIT Mutant Cells

Alison C. Macleod, 2013 .

Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat.

A. Macleod, A. Thomson, P. Whiting, 1993, Immunopharmacology and immunotoxicology.

Inhibition of HSP90 by AT13387 Delays the Emergence of Resistance to BRAF Inhibitors and Overcomes Resistance to Dual BRAF and MEK Inhibition in Melanoma Models

Kristina M. Ilieva, V. Petrenko, V. Sondak, 2014, Molecular Cancer Therapeutics.

Induction of nitric oxide synthase in human mesangial cells.

A. Macleod, N. Haites, N. Benjamin, 1993, Biochemical and biophysical research communications.

Histocompatibility: An Historical Perspective

Alison C. Macleod, A. Macleod, 1985, Journal of the Royal College of Physicians of London.